Discontinuation report ACT ROSUVASTATIN

Last updated on 2018-10-22 History
Report ID 65308
Drug Identification Number 02339765
Brand name ACT ROSUVASTATIN
Common or Proper name ROSUVASTATIN
Company Name ACTAVIS PHARMA COMPANY
Active Ingredient(s) ROSUVASTATIN
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-07-31
Remaining supply date 2018-07-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Transitioned. TEVA available
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2018-10-22 French Compare
v2 2018-10-22 English Compare
v1 2018-10-22 English Compare